Tuesday, November 5, 2024
HomeTagsSonelokimab

Sonelokimab

Moonlake Immunotherapeutics to Initiate Global Phase 2 Study of the Nanobody Sonelokimab in Patients

MoonLake Immunotherapeutics AG ("MoonLake"), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, announced that it is proceeding with a global...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics